Enliven: Challenges in Cancer Detection and Therapy | Open Access Journals | Open Access Articles


Sheri Nixdorf, PhD, BS

Editorial Board Member

"Sheri Nixdorf is a Research Associate at Cure for Life Foundation Neuro-Oncology Laboratory and her research interests include Ovarian Cancer is called a 'silent killer' because of the non-specific symptoms and thus late detection of this disease. Therefore, identification of novel tumour markers for diagnosis and prognosis of Ovarian Cancer comprises the main focus of research efforts. Discovery of sensitive and specific biomarkers for Ovarian Cancer involves collaborations with hospitals and other research institutes, both locally and internationally. Glycan arrays are utilised to screen serum samples from Ovarian Cancer patients and isolate potential biomarkers of disease. Dr. Sheri Nixdorf is a member of the Australian Society for Medical Research (ASMR), Member of the American Association of Cancer Research (AACR). "